Functionalized carbon nanotubes for anticancer drug delivery

Expert Review of Medical Devices

Volumn 8, Issue 5, 2011, Pages 561-566

  Lay, Chee Leng ^a,b   Liu, Jing ^a   Liu, Ye ^a  

^a INSTITUTE OF MATERIALS RESEARCH AND ENGINEERING   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

cancer therapy; carbon nanotubes; cisplatin; doxorubicin; drug delivery; functionalization; paclitaxel; pharmacokinetics; poly(ethylene glycol); toxicity

Indexed keywords

CANCER THERAPY; CIS-PLATIN; DOXORUBICIN; FUNCTIONALIZATIONS; PACLITAXEL;

BIOCOMPATIBILITY; CARBON NANOTUBES; DRUG THERAPY; ETHYLENE; GLYCOLS; PLATINUM COMPOUNDS; POLYETHYLENE GLYCOLS;

CONTROLLED DRUG DELIVERY;

10 HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CARBON NANOTUBE; CARBORANE DERIVATIVE; CISPLATIN; DEXAMETHASONE; DOXORUBICIN; MACROGOL; METHOTREXATE; PACLITAXEL; TAXOID;

AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; CANCER THERAPY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; CELL LINE; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; NANOTECHNOLOGY; NANOTUBES, CARBON; PACLITAXEL; POLYETHYLENE GLYCOLS; RNA, SMALL INTERFERING;

EID: 80052276439     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.11.34     Document Type: Article

References (61)

1. Farokhzad OC, Langer R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliver. Rev. 58(14), 1456-1459 (2006).
2. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7(9), 771-782 (2008).
3. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751-760 (2007).
4. Pastorin G. Crucial functionalizations of carbon nanotubes for improved drug delivery: A valuable option? Pharm. Res. 26(4), 746-769 (2009).
5. Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: From toxicology to pharmacology. Adv. Drug Deliver. Rev. 58(14), 1460-1470 (2006).
6. Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Curr. Opin. Chem. Biol. 9(6), 674-679 (2005).
7. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem. Commun. 5, 571-577 (2005).
8. Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes in drug design and discovery. Accounts Chem. Res. 41(1), 60-68 (2008).
9. Lu FS, Gu LR, Meziani MJ et al. Advances in bioapplications of carbon nanotubes. Adv. Mater. 21(2), 139-152 (2009).
10. Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 4(10), 627-633 (2009).
11. Liu Z, Chen K, Davis C et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 68(16), 6652-6660 (2008).
12. Tasis D, Tagmatarchis N, Bianco A, Prato M. Chemistry of carbon nanotubes. Chem. Rev. 106(3), 1105-1136 (2006).
13. Liu Y, Wu DC, Zhang WD et al. Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. Angew. Chem. Int. Edit. 44(30), 4782-4785 (2005).
14. Lo MY, Lay CL, Lu XH, Liu Y. Finer structures of polyelectrolyte multilayers reflected by solution H-1 NMR. J. Phys. Chem. B. 112(42), 13218-13224 (2008).
15. Liu Z, Sun XM, Nakayama-Ratchford N, Dai HJ. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano. 1(1), 50-56 (2007).
16. Liu Z, Winters M, Holodniy M, Dai HJ. siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew. Chem. Int. Edit. 46(12), 2023-2027 (2007).
17. Ren YP, Pastorin G. Incorporation of hexamethylmelamine inside capped carbon nanotubes. Adv. Mater. 20(11), 2031-2036 (2008).
18. Yanagi K, Miyata Y, Kataura H. Highly stabilized b-carotene in carbon nanotubes. Adv. Mater. 18(2), 437-441 (2006).
19. Kam NWS, Liu Z, Dai HJ. Carbon nanotubes as intracellular transporters for proteins and DNA: An investigation of the uptake mechanism and pathway. Angew. Chem. Int. Edit. 45(4), 577-581 (2006).
20. Lay CL, Liu HQ, Tan HR, Liu Y. Delivery of paclitaxel by physically loading onto poly(ethyleneglycol) (PEG)-graft carbon nanotubes for potent cancer therapeutics. Nanotechnology 21(6), 065101 (2010).
21. Liu Z, Fan AC, Rakhra K et al. Supramolecular p-stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Angew. Chem. Int. Edit. 48(41), 7668-7672 (2009).
22. Liu Z, Tabakman SM, Chen Z, Dai HJ. Preparation of carbon nanotube bioconjugates for biomedical applications. Nat. Protoc. 4(9), 1372-1382 (2009).
23. Kostarelos K, Lacerda L, Pastorin G et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2(2), 108-113 (2007).
24. Schipper ML, Nakayama-Ratchford N, Davis CR et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat. Nanotechnol. 3(4), 216-221 (2008).
25. Liu Z, Davis C, Cai WB, He L, Chen XY, Dai HJ. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl Acad. Sci. USA 105(5), 1410-1415 (2008).
26. Yang ST, Fernando KAS, Liu JH et al. Covalently PEGylated carbon nanotubes with stealth character in vivo. Small 4(7), 940-944 (2008).
27. Chen JY, Chen SY, Zhao XR, Kuznetsova LV, Wong SS, Ojima I. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. J. Am. Chem. Soc. 130(49), 16778-16785 (2008).
28. Yinghuai Z, Peng AT, Carpenter K, Maguire JA, Hosmane NS, Takagaki M. Substituted carborane-appended water-soluble single-wall carbon nanotubes: New approach to boron neutron capture therapy drug delivery. J. Am. Chem. Soc. 127(27), 9875-9880 (2005).
29. Liu Z, Tabakman S, Welsher K, Dai HJ. Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery. Nano Res. 2(2), 85-120 (2009).
30. Hong SY, Tobias G, Al-Jamal KT et al. Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat. Mater. 9(6), 485-490 (2010).
31. Samori C, Ali-Boucetta H, Sainz R et al. Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers. Chem. Commun. 46(9), 1494-1496 (2010).
32. Zhang XK, Meng LJ, Lu QG, Fei ZF, Dyson PJ. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials 30(30), 6041-6047 (2009).
33. Kam NWS, Dai HJ. Carbon nanotubes as intracellular protein transporters: Generality and biological functionality. J. Am. Chem. Soc. 127(16), 6021-6026 (2005).
34. Pantarotto D, Singh R, McCarthy D et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew. Chem. Int. Edit. 43(39), 5242-5246 (2004).
35. Singh R, Pantarotto D, McCarthy D et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: Toward the construction of nanotube-based gene delivery vectors. J. Am. Chem. Soc. 127(12), 4388-4396 (2005).
36. Herrero MA, Toma FM, Al-Jamal KT et al. Synthesis and characterization of a carbon nanotube-dendron series for efficient siRNA delivery. J. Am. Chem. Soc. 131(28), 9843-9848 (2009).
37. Delogu LG, Magrini A, Bergamaschi A et al. Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes. Bioconjugate Chem. 20(3), 427-431 (2009).
38. Kam NWS, O'Connell M, Wisdom JA, Dai HJ. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl Acad. Sci. USA 102(33), 11600-11605 (2005).
39. Kang B, Yu DC, Dai YD, Chang SQ, Chen D, Ding YT. Cancer-cell targeting and photoacoustic therapy using carbon nanotubes as 'bomb' agents. Small 5(11), 1292-1301 (2009).
40. Podesta JE, Al-Jamal KT, Herrero MA et al. Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. Small 5(10), 1176-1185 (2009).
41. Liu Z, Cai WB, He LN et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2(1), 47-52 (2007).
42. Ali-Boucetta H, Al-Jamal KT, McCarthy D, Prato M, Bianco A, Kostarelos K. Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem. Commun. (4), 459-461 (2008).
43. Murakami T, Ajima K, Miyawaki J, Yudasaka M, Iijima S, Shiba K. Drug-loaded carbon nanohorns: Adsorption and release of dexamethasone in vitro. Mol. Pharmaceutics 1(6), 399-405 (2004).
44. Chaudhuri P, Soni S, Sengupta S. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma. Nanotechnology 21(2), 025102 (2010).
45. Chaudhuri P, Harfouche R, Soni S, Hentschel DM, Sengupta S. Shape effect of carbon nanovectors on angiogenesis. ACS Nano. 4(1), 574-582 (2010).
46. Feazell RP, Nakayama-Ratchford N, Dai H, Lippard SJ. Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(iv) anticancer drug design. J. Am. Chem. Soc. 129(27), 8438-8439 (2007).
47. Dhar S, Liu Z, Thomale J, Dai H, Lippard SJ. Targeted single-wall carbon nanotube-mediated Pt(iv) prodrug delivery using folate as a homing device. J. Am. Chem. Soc. 130(34), 11467-11476 (2008).
48. Bhirde AA, Patel V, Gavard J et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 3(2), 307-316 (2009).
49. Prencipe G, Tabakman SM, Welsher K et al. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J. Am. Chem. Soc. 131(13), 4783-4787 (2009).
50. Lay CL, Liu HQ, Wu DC, Liu Y. Poly(ethylene glycol)-graft-hollow silica vesicles for drug delivery. Chem. Eur. J. 16(10), 3001-3004 (2010).
51. Lee JCM, Bermudez H, Discher BM et al. Preparation, stability, and in vitro performance of vesicles made with diblock copolymers. Biotechnol. Bioeng. 73(2), 135-145 (2001).
52. Medical Applications of Liposomes. Lasic DD, Papahadjopoulos D (Eds). Elsevier Science, Amsterdam, The Netherlands (1998).
53. Haag R, Kratz F. Polymer therapeutics: Concepts and applications. Angew. Chem. Int. Edit. 45(8), 1198-1215 (2006).
54. Wu W, Li R, Bian X et al. Covalently combining carbon nanotubes with anticancer agent: Preparation and antitumor activity. ACS Nano. 3(9), 2740-2750 (2009).
55. Zhou FF, Xing D, Wu BY, Wu SN, Ou ZM, Chen WR. New insights of transmembranal mechanism and subcellular localization of noncovalently modified single-walled carbon nanotubes. Nano Lett. 10(5), 1677-1681 (2010).
56. Raffa V, Ciofani G, Nitodas S et al. Can the properties of carbon nanotubes influence their internalization by living cells? Carbon 46, 1600-1610 (2008).
57. Antonelli A, Serafini S, Menotta M et al. Improved cellular uptake of functionalized single-walled carbon nanotubes. Nanotechnology 21, 425101-425115 (2010).
58. Jin H, Heller DA, Sharma R, Strano MS. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: Single particle tracking and a generic uptake model for nanoparticles. ACS Nano. 3(1), 149-158 (2009).
59. Singh R, Pantarotto D, Lacerda L et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl Acad. Sci. USA 103(9), 3357-3362 (2006).
60. Cherukuri P, Gannon CJ, Leeuw TK et al. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc. Natl Acad. Sci. USA 103(50), 18882-18886 (2006).
61. Kagan VE, Konduru NV, Feng WH et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotechnol. 5(5), 354-359 (2010).